Efnisyfirlit

• Preface
• Contents
• Contributors
• Abbreviations
• Chapter 1. Molecular Biotechnology
• Chapter 2. Biophysical and Biochemical Analysis of Recombinant Proteins
• Chapter 3. Production and Downstream Processing of Biotech Compounds
• Chapter 4. Formulation of Biotech Products, Including Biopharmaceutical Considerations
• Chapter 5. Pharmacokinetics and Pharmacodynamics of Peptide and Protein Drugs
• Chapter 6. Immunogenicity of Therapeutic Proteins
• Chapter 7. Genomics, Other “Omics” Technologies, Personalized Medicine, and Additional Biotechnology
• Chapter 8. Gene Theapy
• Chapter 9. Oligonucleotides
• Chapter 10. Hematopoietic Growth Factors
• Chapter 11. Interferons and Interleukins
• Chapter 12. Insulin
• Chapter 13. Growth Hormones
• Chapter 14. Recombinant Coagulation Factors and Thrombolytic Agents
• Chapter 15. Monoclonal Antibodies: From Structure to Therapeutic Applications
• Chapter 16. Monoclonal Antibodies in Cancer
• Chapter 17. Monoclonal Antibodies in Solid Organ Transplantation
• Chapter 18. Monoclonal Antibodies in Anti-inflammatory Therapy
• Chapter 19. Recombinant Human Deoxyribonuclease I
• Chapter 20. Follicle-Stimulating Hormone
• Chapter 21. Vaccines
• Chapter 22. Dispensing Biotechnology Products: Handling Professional Education, and Product Informat
• Chapter 23. Economic Considerations in Medical Biotechnology
• Chapter 24. Regulatory Issues and Drug Product Approval for Biopharmaceuticals
• Questions and Answers
• Index
• Back cover